The family-owned investment company Kirk Kapital has increased its ownership interest in the Danish pharmaceutical company Ferrosan Medical Devices.
This was part of a large refinancing of Ferrosan Medical Devices in which Kirk Kapital has subscribed for preference shares.
Ferrosan Medical Devices is a leading developer and manufacturer of haemostatic products used to stop bleeding during surgery. The products are marketed and distributed in more than 100 countries.
Kirk Kapital manages approx. DKK 8bn, and the investments include minority interests in Alliance+, Globeteam, Kompan, Tacton and TPS.
Mads Ilum and Jonas Bang advised Kirk Kapital in connection with the investment.